Ideaya Biosciences Inc
IDYA
Market Cap$1.87B
Close$
$-1.44
106.9% downside
Current Fair Value
106.9% downsideOvervalued by 106.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.87 Billion |
|---|---|
| Enterprise Value | $1.77 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.36 |
| Beta | 0.02 |
| Outstanding Shares | 88,356,335 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.16 |
|---|---|
| PEG | -7.66 |
| Price to Sales | - |
| Price to Book Ratio | 1.91 |
| Enterprise Value to Revenue | 252.51 |
| Enterprise Value to EBIT | -4.91 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata